You are here

Prices & Quotes - UK Markets - Polarean Imaging (POLX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 61.00p
Change Today:
-1.50p
Market Cap:
127.53m
Sector:
Health Care Equipment & Services

POLX Overview

Polarean is a clinical-stage company with a core technology that is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe ("HPX") using MRI technology to help diagnose lung disease earlier, identify the type of intervention likely to benefit a patient, and to monitor the efficacy of treatment. It is currently being used at a number of research sites on a pre-FDA clearance basis to facilitate the research and evaluation of lung function, to assist in making improved disease progression assessment and to clearly visualise the effectiveness of several therapeutics which are under development.

Today (Fri 22 Oct 21)

1 Day Chart

Last 6 Month

6 Month Chart

POLX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.88 (1.06) (98.85)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 1.24 (3.96) (13.88)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 2.44 (5.45) (7.79)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 2.30 (6.10) (5.69)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 1.06 (6.53) (4.39)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

POLX Market Data

Currency UK Pounds
Price 61.00p
Change Today -1.50p
52 Week High 106.50p
52 Week Low 42.80p
Volume 355,447
Shares Issued 209.07m
Market Cap 127.53m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

POLX Dividends

No dividends found

Trades for 22-Oct-2021

Time Volume / Share Price
16:05 417 @ 62.68p
16:02 2,540 @ 59.25p
16:02 10,000 @ 60.05p
15:55 4,000 @ 63.00p
15:54 10,000 @ 60.11p

POLX Key Personnel

CEO Richard Hullihen
CFO Charles Osborne